Island Pharma Jumps After Emergency-Use Approval for Ebola Drug

🇦🇺 Bloomberg (AU) —

AI Summary

Island Pharmaceuticals Ltd. from Australia saw its shares jump 47% after receiving emergency-use approval for its experimental antiviral drug galidesivir to treat the Ebola Bundibugyo strain in Uganda. Regulatory and ethical approvals facilitated rapid market enthusiasm.

Australia’s Island Pharmaceuticals Ltd. surged as much as 47% after saying its experimental antiviral galidesivir had secured regulatory and ethics approvals for emergency use in patients with the Bundibugyo strain of Ebola in Uganda.

Markets Deals Health Island Pharmaceuticals Ebola drug galidesivir emergency use stock surge Uganda

Read original source →